Brief: Akoustis Reports Record Q2 Revenue At $3.7 Mln
Jan 31 (Reuters) - Akoustis Technologies Inc AKTS.O :
* AKOUSTIS REPORTS RECORD REVENUE FOR SECOND QUARTER FISCAL
2022
ON 96% SEQUENTIAL GROWTH
* Q2 REVENUE $3.7 MILLION
* QTRLY LOSS PER SHARE $0.29
* Q2 EARNINGS PER SHARE VIEW $-0.21, REVENUE VIEW $3.8
MILLION --
REFINITIV IBES DATA
* QTRLY ADJUSTED LOSS PER SHARE $0.23
Source text for Eikon: ID:nGNXblRLtT
Further company coverage: AKTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aktis Oncology
See all newsAktis Oncology Q2 net loss widens on higher R&D, administrative costs
U.S. RESEARCH ROUNDUP-Danaher, GM, MSCI
Aktis Oncology Q1 net loss widens on increased IPO-related expenses
Generate Biomedicines shares fall 6% in weak Nasdaq debut for drug developer (updated)
Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut